Literature DB >> 32533249

Advancing clinical response characterization to frontotemporal transcranial direct current stimulation with electric field distribution in patients with schizophrenia and auditory hallucinations: a pilot study.

Marine Mondino1,2,3, Clara Fonteneau1,2,3, Louis Simon1,2,3, Clément Dondé1,2,3, Frédéric Haesebaert1,2,3, Emmanuel Poulet1,2,3,4, Jerome Brunelin5,6,7.   

Abstract

Transcranial direct current stimulation (tDCS) has been proposed as a therapeutic option for treatment-resistant auditory verbal hallucinations (AVH) in schizophrenia. In such cases, repeated sessions of tDCS are delivered with the anode over the left prefrontal cortex and the cathode over the left temporoparietal junction. Despite promising findings, the clinical response to tDCS is highly heterogeneous among patients. Here, we explored baseline differences between responders and nonresponders to frontotemporal tDCS using electric field modeling. We hypothesized that responders would display different tDCS-induced electric field strength in the brain areas involved in AVH compared to nonresponders.Using baseline structural MRI scans of 17 patients with schizophrenia and daily AVH who received 10 sessions of active frontotemporal tDCS, we constructed individual realistic whole brain models estimating electric field strength. Electric field maps were compared between responders (n = 6) and nonresponders to tDCS (n = 11) using an independent two-sample t test. Clinical response was defined as at least a 50% decrease of AVH 1 month after the last tDCS session.Results from the electric field map comparison showed that responders to tDCS displayed higher electric field strength in the left transverse temporal gyrus at baseline compared to nonresponders (T = 2.37; p = 0.016; 32 voxels).These preliminary findings suggested that the strength of the tDCS-induced electric field reaching the left transverse temporal gyrus could play an important role in the response to frontotemporal tDCS. In addition, this work suggests the interest of using electric field modeling to individualize tDCS and increase response rate.

Entities:  

Keywords:  Auditory hallucinations; Electric field; Modeling; Schizophrenia; tDCS

Mesh:

Year:  2020        PMID: 32533249     DOI: 10.1007/s00406-020-01149-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  32 in total

1.  Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension study.

Authors:  Joshua T Kantrowitz; Pejman Sehatpour; Michael Avissar; Guillermo Horga; Anna Gwak; Mathew J Hoptman; Odeta Beggel; Ragy R Girgis; Blair Vail; Gail Silipo; Marlene Carlson; Daniel C Javitt
Journal:  Brain Stimul       Date:  2019-03-05       Impact factor: 8.955

2.  Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders.

Authors:  Simon McCarthy-Jones; David Smailes; Aiden Corvin; Michael Gill; Derek W Morris; Timothy G Dinan; Kieran C Murphy; F Anthony O Neill; John L Waddington; Gary Donohoe; Robert Dudley
Journal:  Psychiatry Res       Date:  2017-02-24       Impact factor: 3.222

3.  Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia.

Authors:  J P Lindenmayer; Mila Kirstie C Kulsa; Tania Sultana; Amandeep Kaur; Ran Yang; Isidora Ljuri; Benedicto Parker; Anzalee Khan
Journal:  Brain Stimul       Date:  2018-10-02       Impact factor: 8.955

4.  A Review of the Effects of Transcranial Direct Current Stimulation for the Treatment of Hallucinations in Patients With Schizophrenia.

Authors:  Marine Mondino; Florence Sauvanaud; Jérôme Brunelin
Journal:  J ECT       Date:  2018-09       Impact factor: 3.635

5.  A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders.

Authors:  V M Goghari; M Harrow; L S Grossman; C Rosen
Journal:  Psychol Med       Date:  2012-10-04       Impact factor: 7.723

6.  Efficacy of fronto-temporal transcranial direct current stimulation for refractory auditory verbal hallucinations in schizophrenia: A randomized, double-blind, sham-controlled study.

Authors:  Anushree Bose; Venkataram Shivakumar; Sri Mahavir Agarwal; Sunil V Kalmady; Sonia Shenoy; Vanteemar S Sreeraj; Janardhanan C Narayanaswamy; Ganesan Venkatasubramanian
Journal:  Schizophr Res       Date:  2017-09-01       Impact factor: 4.939

Review 7.  Understanding auditory verbal hallucinations: a systematic review of current evidence.

Authors:  R Upthegrove; M R Broome; K Caldwell; J Ives; F Oyebode; S J Wood
Journal:  Acta Psychiatr Scand       Date:  2015-12-12       Impact factor: 6.392

8.  Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia.

Authors:  Jerome Brunelin; Marine Mondino; Leila Gassab; Frederic Haesebaert; Lofti Gaha; Marie-Françoise Suaud-Chagny; Mohamed Saoud; Anwar Mechri; Emmanuel Poulet
Journal:  Am J Psychiatry       Date:  2012-07       Impact factor: 18.112

Review 9.  Interaction of language, auditory and memory brain networks in auditory verbal hallucinations.

Authors:  Branislava Ćurčić-Blake; Judith M Ford; Daniela Hubl; Natasza D Orlov; Iris E Sommer; Flavie Waters; Paul Allen; Renaud Jardri; Peter W Woodruff; Olivier David; Christoph Mulert; Todd S Woodward; André Aleman
Journal:  Prog Neurobiol       Date:  2016-11-24       Impact factor: 11.685

10.  The Effects of Add-on Fronto-Temporal Transcranial Direct Current Stimulation (tDCS) on Auditory Verbal Hallucinations, Other Psychopathological Symptoms, and Insight in Schizophrenia: A Randomized, Double-Blind, Sham-Controlled Trial.

Authors:  Chuan-Chia Chang; Nian-Sheng Tzeng; Che-Yi Chao; Chin-Bin Yeh; Hsin-An Chang
Journal:  Int J Neuropsychopharmacol       Date:  2018-11-01       Impact factor: 5.176

View more
  6 in total

1.  Ten Sessions of 30 Min tDCS over 5 Days to Achieve Remission in Depression: A Randomized Pilot Study.

Authors:  Rémi Moirand; Laetitia Imbert; Frédéric Haesebaert; Gabrielle Chesnoy; Benoit Bediou; Emmanuel Poulet; Jérôme Brunelin
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

Review 2.  A Literature Mini-Review of Transcranial Direct Current Stimulation in Schizophrenia.

Authors:  Zuzana Stuchlíková; Monika Klírová
Journal:  Front Psychiatry       Date:  2022-04-21       Impact factor: 4.157

3.  Differences in electric field strength between clinical and non-clinical populations induced by prefrontal tDCS: A cross-diagnostic, individual MRI-based modeling study.

Authors:  Yuki Mizutani-Tiebel; Shun Takahashi; Temmuz Karali; Eva Mezger; Lucia Bulubas; Irina Papazova; Esther Dechantsreiter; Sophia Stoecklein; Boris Papazov; Axel Thielscher; Frank Padberg; Daniel Keeser
Journal:  Neuroimage Clin       Date:  2022-04-16       Impact factor: 4.891

4.  Superior temporal gyrus functional connectivity predicts transcranial direct current stimulation response in Schizophrenia: A machine learning study.

Authors:  Animesh Kumar Paul; Anushree Bose; Sunil Vasu Kalmady; Venkataram Shivakumar; Vanteemar S Sreeraj; Rujuta Parlikar; Janardhanan C Narayanaswamy; Serdar M Dursun; Andrew J Greenshaw; Russell Greiner; Ganesan Venkatasubramanian
Journal:  Front Psychiatry       Date:  2022-08-05       Impact factor: 5.435

Review 5.  Applications of open-source software ROAST in clinical studies: A review.

Authors:  Mohigul Nasimova; Yu Huang
Journal:  Brain Stimul       Date:  2022-07-16       Impact factor: 9.184

6.  Standard Non-Personalized Electric Field Modeling of Twenty Typical tDCS Electrode Configurations via the Computational Finite Element Method: Contributions and Limitations of Two Different Approaches.

Authors:  Andrés Molero-Chamizo; Michael A Nitsche; Carolina Gutiérrez Lérida; Ángeles Salas Sánchez; Raquel Martín Riquel; Rafael Tomás Andújar Barroso; José Ramón Alameda Bailén; Jesús Carlos García Palomeque; Guadalupe Nathzidy Rivera-Urbina
Journal:  Biology (Basel)       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.